Ken Griffin’s Maze Therapeutics MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.9M Buy
1,579,818
+727,142
+85% +$20.2M ﹤0.01% 1702
2026
Q2
$25.4M Buy
852,676
+76,962
+10% +$2.02M ﹤0.01% 2276
2026
Q1
$23.2M Buy
775,714
+327,497
+73% +$14.5M ﹤0.01% 2156
2025
Q4
$18.6M Buy
+448,217
New +$15.4M ﹤0.01% 2452
2025
Q2
– Sell
-20,000
Closed -$220K – 15695
2025
Q1
$220K Buy
+20,000
New +$241K ﹤0.01% 10264

Other funds holding MAZE

Ken Griffin's MAZE Position: Q3 2026 in Review

Ken Griffin increased its Maze Therapeutics (MAZE) stake by 85% in Q3 2026, buying an estimated $20.2M and bringing the position to 1,579,818 shares worth $42.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

Ken Griffin first reported a position in MAZE in Q1 2025 and has held it in 5 quarters since. 158 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.

  • Ken Griffin held 1,579,818 shares of Maze Therapeutics worth $42.9M as of Q3 2026.
  • Ken Griffin bought 727,142 Maze Therapeutics shares in Q3 2026, an estimated $20.2M.
  • Maze Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1702 holding.
  • Ken Griffin first reported a position in Maze Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 158 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.